🟢 HCW Biologics is trading 7% up in pre-market with no clear catalyst identified

HCW Biologics is trading at $1.83, up 7.02%, in pre-market on October 1, with no clear company-specific catalyst identified.

• Its latest news-release page lists announcements dated September 8 and September 2, with no October 1 release shown.
• The company announced a $1.5 million private placement on September 24, but available information does not connect it to this morning’s move.
• Broader market signals are mixed and do not establish a clear explanation for the gain.